Categories
News

Covid 19 Omicron: South African GP who raised alarm about Omicron says she was pressured not to call it ‘mild’ – NZ Herald

The South African GP who first raised the alarm about Omicron says she was pressured by governments “not to publicly state that it was a mild illness”.

Dr Angelique Coetzee told Germany’s Die Welt newspaper this week that European governments asked her to portray the new strain as just as serious as previous Covid-19 variants, including Delta.

“I was told not to publicly state that it was a mild illness,” she said. “I have been asked to refrain from making such statements and to say that it is a serious illness. I declined.”

Asked what she meant, Coetzee said “based on the clinical picture there are no indications that we are dealing with a very serious disease”.

http://archive.today/2022.02.12-083002/https://www.nzherald.co.nz/world/covid-19-omicron-south-african-gp-who-raised-alarm-about-omicron-says-she-was-pressured-not-to-call-it-mild/XJ5H7I6E2LKVM5S655ET5HLIWI/

Categories
News

Covid vaccine latest: AstraZeneca now linked to ‘transverse myelitis’ – MHRA warning – The Express

ASTRAZENECA, now referred to as Vaxzevria by the Medicines and Healthcare Regulatory Agency (MHRA), has been associated with cases of transverse myelitis – i.e. inflammation of the spinal cord.

As of Wednesday, January 26, transverse myelitis has officially been added to the “warnings and precautions [of] neurological events” section given to healthcare professionals. The MHRA has assured that cases are “extremely rare” but the reaction can lead to: muscle weakness, localised or radiating back pain, and bladder issues. Furthermore, transverse myelitis can lead to bowel symptoms and changes in sensations.

http://archive.today/2022.01.28-233341/https://www.express.co.uk/life-style/health/1556323/covid-vaccine-latest-astrazeneca-transverse-myelitis-spinal-inflammation

Categories
News

Johnson & Johnson COVID Vaccine Recipients Almost 4X as Likely to Get Blood Clots: Study – Newsweek

A new study conducted in one county in Minnesota has found an increased likelihood that citizens who received the Johnson & Johnson’s COVID-19 vaccine were more likely to develop blood clots.

The study by the Mayo Clinic found that recipients of the Johnson & Johnson vaccine, officially designated “Janssen,” in Olmsted County, Minnesota, were about 3.7 times more likely to develop a certain variety of cerebral blood clots. Case numbers taken from February 28 to May 7, 2021, were compared to pre-pandemic levels of the blood clots from January 1, 2001, through December 31, 2015.

http://archive.today/2021.11.03-081828/https://www.newsweek.com/johnson-johnson-covid-vaccine-recipients-almost-4x-likely-get-blood-clots-study-1645100

Categories
Publications

Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination JAMA

In this population-based cohort study, we found that the CVST incidence rate 15 days after Ad26.COV2.S vaccination was significantly higher than the prepandemic rate. However, the higher rate of this rare adverse effect must be considered in the context of the effectiveness of the vaccine in preventing COVID-19 (absolute reduction of severe or critical COVID-19 of 940 per 100 000 PY).

http://archive.today/2021.11.02-171706/https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785610

Categories
News

How Many More Will Die From Fear of the Coronavirus? – New York Times

Cleveland Clinic CEO and Mayo Clinic President say the response to COVID-19 could be as big a disaster as the virus itself.

“The true cost of this epidemic will not be measured in dollars; it will be measured in human lives and human suffering. In the case of cancer alone, our calculations show we can expect a quarter of a million additional preventable deaths annually if normal care does not resume,” they wrote.

https://www.nytimes.com/2020/06/09/opinion/coronavirus-hospitals-deaths.html